CCR2 and central nervous system cancer: FACS measurements showed increased VCAM1-positive TAMs and CCR2+ TAM precursor cells in Sr-a1−/− glioma compared with Sr-a1+/+ glioma (Figure 3Db & 3Dc), confirming that SR-A1 deletion could increase TAM infiltration.